Hendrik Peter Scholl - 18 Mar 2026 Form 3 Insider Report for BELITE BIO, INC (BLTE)

Role
Chief Medical Officer
Signature
/s/ Hendrik Peter Scholl
Issuer symbol
BLTE
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 15:32:49 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scholl Hendrik Peter Chief Medical Officer GOTTHARDSTRASSE 26, ZUG, SWITZERLAND /s/ Hendrik Peter Scholl 18 Mar 2026 0002113223

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BLTE Ordinary Share 35,000 18 Mar 2026 By Bioptima Ltd.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 100,000 $48.68 By Bioptima Ltd. F1
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 75,000 $54.88 By Bioptima Ltd. F2
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 40,000 $158.36 By Bioptima Ltd. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest (i) as to 50,000 ordinary shares on the first anniversary of September 1, 2024, and (ii) as to 50,000 ordinary shares in 24 equal and continuous monthly installments for each full month following the first anniversary of September 1, 2024, subject to continued service to the Issuer on each such date.
F2 The option shall vest (i) as to 12,500 ordinary shares on September 1, 2025, and (ii) as to 62,500 ordinary shares in 30 equal and continuous monthly installments for each full month following September 1, 2025, subject to continued service to the Issuer on each such date.
F3 The option shall vest (i) as to 13,333 ordinary shares on January 9, 2027, (ii) as to 13,333 ordinary shares on January 9, 2028, and (iii) as to 13,334 ordinary shares on January 9, 2029.

Remarks:

Exhibit 24 - Power of Attorney